Starling Oncology, Inc. Other Current Liabilities
Starling Oncology, Inc. (STLN) had Other Current Liabilities of $27.43 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Current $27.43M.
- 2026-03-31: Other Liabilities, Current $24.30M.
- 2025-12-31: Other Liabilities, Current $20.64M.
- 2025-09-30: Other Liabilities, Current $22.79M.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $27.43M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $24.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $20.64M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $22.79M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $22.89M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $23.43M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $21.09M 10-K · filed 2026-03-12 |
| 2024-09-30 | $15.44M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $12.83M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $18.36M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $14.00M 10-K · filed 2025-03-26 |
| 2023-09-30 | $12.72M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $14.13M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $12.24M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $14.60M 10-K · filed 2024-03-28 |
| 2022-09-30 | $16.15M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $17.61M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.52M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $13.92M 10-K · filed 2023-03-16 |
| 2020-12-31 | $9.45M 10-K · filed 2022-03-11 |